COLL  valuation analysis

Basics
Name: Collegium Pharmaceutical Inc
Description: Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 10, 2022
Market cap: $537.10M (1350th)
Sales(TTM): $272.90M (1334th)
Earnings(TTM): $42.79M (1148th)

Value
FFER: 0.52*
Actual price: $15.95
* Earnings were reported Aug 03, 2022 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Collegium Pharmaceutical Inc's operating income decreased from $72.36M to -$13.58M in the last year.
Earnings / MarketCap
Collegium Pharmaceutical Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Collegium Pharmaceutical Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Collegium Pharmaceutical Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Collegium Pharmaceutical Inc
"Drug Manufacturers-Specialty & Generic" industry